Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Adenosine Monophosphate | HCID 6083 | — |
| Reactant | HCID 178508819 | HCID 178508819 | — |
| Product | Camp | HCID 6076 | — |
Reaction Steps
The adenylate cyclase activity induced by each of the tested polypeptides of the invention was also measured in SaOS-2/B 10 cells as described previously (Rodain et al., J. Clin. Invest. (1983) 72,1511; Goldman, et al., Endocrinology (1988) 123, 1468). Conflúnt SaOS-2/B10 cells in 24 wells plates were incubated with 0.5 μCi [3H]adenine (26.9 Ci/mmol, New England Nuclear, Boston, Mass. in fresh medium at 37° C. for 2 hrs. and washed twice with Hank's solution. The cells were treated with 1 mM IBMX (isobutylmethylxanthine, Sigma, St. Louis, Mo.) in fresh medium for 15 min. and a tested PTH analog was added to the medium to incubate for 5 min. The reaction was stopped by the addition of 1.2M TCA followed by sample neutralization with 4N KOH. Cyclic AMP was isolated by the two-column chromatographic method (Salomon, et al., Anal. Biochem. (1974) 58, 541). The radioactivity was counted in a scintillation counter (Liquid scintillation counter 2200CA, PACKARD, Downers Grove, Ill.). The EC50s (half maximal stimulation of adenylate cyclase) were calculated for the tested PTH analogs and are shown in Table 4 below:
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US07799757B2 |
|---|
| Source dataset | uspto-grants-2010_09 |
|---|
| ORD ID | ord-f65a4716835240ba91ec6cbb46df1a58 |
|---|
| Source note | uspto-grants-2010_09 |
|---|